TELA Bio, Inc. is a commercial stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. Our growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials.
We are committed to delivering our advanced technologies with a strong economic value proposition with flexible inventory consignment options to assist surgeons and institutions in providing next-generation soft-tissue repair solutions to more patients worldwide.